Search

Omar Casillashernandez

Examiner (ID: 12919, Phone: (571)270-5432 , Office: P/2689 )

Most Active Art Unit
2689
Art Unit(s)
2689
Total Applications
789
Issued Applications
579
Pending Applications
71
Abandoned Applications
147

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 15898427 [patent_doc_number] => 20200148732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-14 [patent_title] => SMALL MOLECULES BLOCKING HISTONE READER DOMAINS [patent_app_type] => utility [patent_app_number] => 16/699435 [patent_app_country] => US [patent_app_date] => 2019-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22625 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16699435 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/699435
Small molecules blocking histone reader domains Nov 28, 2019 Issued
Array ( [id] => 17343628 [patent_doc_number] => 20220009959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => PEPTIDE LIGANDS FOR CAPTURE OF HOST CELL PROTEINS [patent_app_type] => utility [patent_app_number] => 17/296795 [patent_app_country] => US [patent_app_date] => 2019-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23295 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 171 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17296795 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/296795
PEPTIDE LIGANDS FOR CAPTURE OF HOST CELL PROTEINS Nov 25, 2019 Pending
Array ( [id] => 18932342 [patent_doc_number] => 11884749 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-30 [patent_title] => Compositions and methods for treating endometriosis [patent_app_type] => utility [patent_app_number] => 17/295377 [patent_app_country] => US [patent_app_date] => 2019-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 28272 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17295377 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/295377
Compositions and methods for treating endometriosis Nov 20, 2019 Issued
Array ( [id] => 16499940 [patent_doc_number] => 10865316 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-15 [patent_title] => Conotoxin peptides for use in biofouling deterrence [patent_app_type] => utility [patent_app_number] => 16/685101 [patent_app_country] => US [patent_app_date] => 2019-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7473 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16685101 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/685101
Conotoxin peptides for use in biofouling deterrence Nov 14, 2019 Issued
Array ( [id] => 15931811 [patent_doc_number] => 20200157539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-21 [patent_title] => USE OF THERAPEUTIC AGENTS [patent_app_type] => utility [patent_app_number] => 16/681416 [patent_app_country] => US [patent_app_date] => 2019-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9875 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16681416 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/681416
Use of therapeutic agents Nov 11, 2019 Issued
Array ( [id] => 17546710 [patent_doc_number] => 20220118051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-21 [patent_title] => SELF-ASSEMBLING VEGF NANOPARTICLES [patent_app_type] => utility [patent_app_number] => 17/292265 [patent_app_country] => US [patent_app_date] => 2019-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14360 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17292265 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/292265
SELF-ASSEMBLING VEGF NANOPARTICLES Nov 7, 2019 Pending
Array ( [id] => 18213411 [patent_doc_number] => 20230059675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-23 [patent_title] => TUMOR-SPECIFIC POLYPEPTIDE SEQUENCE AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/774873 [patent_app_country] => US [patent_app_date] => 2019-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7458 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17774873 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/774873
Tumor-specific polypeptide sequence and use thereof Nov 6, 2019 Issued
Array ( [id] => 18428730 [patent_doc_number] => 11673940 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-06-13 [patent_title] => Recombinant production of a collagen peptide preparation and use thereof [patent_app_type] => utility [patent_app_number] => 17/287905 [patent_app_country] => US [patent_app_date] => 2019-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 15952 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17287905 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/287905
Recombinant production of a collagen peptide preparation and use thereof Nov 5, 2019 Issued
Array ( [id] => 15828619 [patent_doc_number] => 20200129591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-30 [patent_title] => COMPOSITION HAVING TISSUE-REPAIRING ACTIVITY, AND USE THEREFOR [patent_app_type] => utility [patent_app_number] => 16/671497 [patent_app_country] => US [patent_app_date] => 2019-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13496 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16671497 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/671497
Composition having tissue-repairing activity, and use therefor Oct 31, 2019 Issued
Array ( [id] => 15589687 [patent_doc_number] => 20200071378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-05 [patent_title] => VSIG8-BASED CHIMERIC PROTEINS [patent_app_type] => utility [patent_app_number] => 16/665803 [patent_app_country] => US [patent_app_date] => 2019-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24537 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16665803 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/665803
VSIG8-based chimeric proteins Oct 27, 2019 Issued
Array ( [id] => 15451295 [patent_doc_number] => 20200038471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-06 [patent_title] => SMALL MOLECULE CANCER TREATMENTS THAT CAUSE NECROSIS IN CANCER CELLS BUT DO NOT AFFECT NORMAL CELLS [patent_app_type] => utility [patent_app_number] => 16/661036 [patent_app_country] => US [patent_app_date] => 2019-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14342 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16661036 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/661036
SMALL MOLECULE CANCER TREATMENTS THAT CAUSE NECROSIS IN CANCER CELLS BUT DO NOT AFFECT NORMAL CELLS Oct 22, 2019 Abandoned
Array ( [id] => 17458783 [patent_doc_number] => 20220072087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-10 [patent_title] => SPECIFIC COMBINATION THERAPY FOR TREATMENT OF PANCREATIC CANCER [patent_app_type] => utility [patent_app_number] => 17/422786 [patent_app_country] => US [patent_app_date] => 2019-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5184 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17422786 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/422786
SPECIFIC COMBINATION THERAPY FOR TREATMENT OF PANCREATIC CANCER Oct 16, 2019 Abandoned
Array ( [id] => 17890747 [patent_doc_number] => 11453700 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-27 [patent_title] => Peptide having activities of skin whitening and uses thereof [patent_app_type] => utility [patent_app_number] => 16/625841 [patent_app_country] => US [patent_app_date] => 2019-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 4 [patent_no_of_words] => 4018 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16625841 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/625841
Peptide having activities of skin whitening and uses thereof Oct 9, 2019 Issued
Array ( [id] => 17336014 [patent_doc_number] => 20220002345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-06 [patent_title] => Bone-Targeting Therapeutic Compositions and Methods of Using Them [patent_app_type] => utility [patent_app_number] => 17/283312 [patent_app_country] => US [patent_app_date] => 2019-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3388 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17283312 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/283312
Bone-Targeting Therapeutic Compositions and Methods of Using Them Oct 7, 2019 Abandoned
Array ( [id] => 19367390 [patent_doc_number] => 12059450 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-08-13 [patent_title] => Anticancer pharmaceutical composition containing IF1 as active ingredient [patent_app_type] => utility [patent_app_number] => 17/281808 [patent_app_country] => US [patent_app_date] => 2019-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 6174 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17281808 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/281808
Anticancer pharmaceutical composition containing IF1 as active ingredient Oct 1, 2019 Issued
Array ( [id] => 16191109 [patent_doc_number] => 20200231958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-23 [patent_title] => FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND A METHOD FOR ITS PRODUCTION [patent_app_type] => utility [patent_app_number] => 16/589851 [patent_app_country] => US [patent_app_date] => 2019-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11967 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16589851 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/589851
FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND A METHOD FOR ITS PRODUCTION Sep 30, 2019 Abandoned
Array ( [id] => 17426065 [patent_doc_number] => 20220053773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-24 [patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOGENIC INFECTIONS IN PLANTS [patent_app_type] => utility [patent_app_number] => 17/281884 [patent_app_country] => US [patent_app_date] => 2019-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37290 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17281884 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/281884
COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOGENIC INFECTIONS IN PLANTS Sep 30, 2019 Pending
Array ( [id] => 15361495 [patent_doc_number] => 20200016512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-16 [patent_title] => AFFINITY SEPARATION MATRIX FOR PURIFYING IMMUNOGLOBULIN [patent_app_type] => utility [patent_app_number] => 16/586054 [patent_app_country] => US [patent_app_date] => 2019-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10155 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16586054 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/586054
AFFINITY SEPARATION MATRIX FOR PURIFYING IMMUNOGLOBULIN Sep 26, 2019 Abandoned
Array ( [id] => 20621654 [patent_doc_number] => 12589148 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-31 [patent_title] => Immunity-inducing agent comprising antigen peptide-adjuvant nucleotide conjugate and pharmaceutical composition comprising same [patent_app_type] => utility [patent_app_number] => 17/280605 [patent_app_country] => US [patent_app_date] => 2019-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 6896 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 190 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17280605 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/280605
Immunity-inducing agent comprising antigen peptide-adjuvant nucleotide conjugate and pharmaceutical composition comprising same Sep 26, 2019 Issued
Array ( [id] => 17198493 [patent_doc_number] => 20210338587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-04 [patent_title] => INJECTABLE COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/279807 [patent_app_country] => US [patent_app_date] => 2019-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17932 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17279807 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/279807
INJECTABLE COMPOSITION Sep 26, 2019 Pending
Menu